# Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES

> **NCT04135989** · PHASE4 · UNKNOWN · sponsor: **Federico II University** · enrollment: 2106 (estimated)

## Conditions studied

- Coronary Artery Disease
- Acute Coronary Syndrome
- Chronic Coronary Syndrome
- Myocardial Infarction

## Interventions

- **DEVICE:** Percutaneous coronary intervention with implantation of amphilimus-eluting stents for coronary artery disease.
- **DEVICE:** Percutaneous coronary intervention with implantation of everolimus-eluting stents for coronary artery disease.
- **DRUG:** Personalized DAPT duration
- **DRUG:** Standard DAPT duration

## Key facts

- **NCT ID:** NCT04135989
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2021-10-24
- **Final completion:** 2024-10-24
- **Target enrollment:** 2106 (ESTIMATED)
- **Last updated:** 2024-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04135989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04135989, "Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04135989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*